Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Lukens, John R ^a   Dolina, Joseph S ^a   Kim, Taeg S ^a   Tacke, Robert S ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GAMMA INTERFERON; LIVER ANTIGEN; VIRUS ANTIGEN; ANTIVIRUS AGENT; CYTOKINE;

ADENOVIRUS INFECTION; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; IMMUNE RESPONSE; LIVER FUNCTION; LIVER PARENCHYMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; COCULTURE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LIVER; METABOLISM; METHODOLOGY; SPLEEN; TRANSGENIC MOUSE; VIROLOGY;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); MURINAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; FLOW CYTOMETRY; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN;

EID: 70449337955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007619     Document Type: Article

References (51)

1. Crispe IN (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3: 51-62.
2. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, et al. (1969) Induction of immunological tolerance by porcine liver allografts. Nature 223: 472-476.
3. Calne R, Davies H (1994) Organ graft tolerance: the liver effect. Lancet 343: 67-68.
4. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY (1995) Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59: 919-921.
5. Huang L, Sye K, Crispe IN (1994) Proliferation and apoptosis of B220+CD4-CD8-TCR alpha beta intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int Immunol 6: 533-540.
6. Wack A, Corbella P, Harker N, Crispe IN, Kioussis D (1997) Multiple sites of post-activation CD8+ T cell disposal. Eur J Immunol 27: 577-583.
7. Mehal WZ, Juedes AE, Crispe IN (1999) Selective retention of activated CD8+ T cells by the normal liver. J Immunol 163: 3202-3210.
8. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
9. Chisari FV (1997) Cytotoxic T cells and viral hepatitis. J Clin Invest 99: 1472-1477.
10. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, et al. (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578-582.
11. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911-4927.
12. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
13. Grayson JM, Weant AE, Holbrook BC, Hildeman D (2006) Role of Bim in regulating CD8+ T-cell responses during chronic viral infection. J Virol 80: 8627-8638.
14. van Faassen H, Dudani R, Krishnan L, Sad S (2004) Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes. J Immunol 172: 3491-3500.
15. Fleischer B, Fleischer S, Maier K, Wiedmann KH, Sacher M, et al. (1990) Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 69: 14-19.
16. Belz GT, Altman JD, Doherty PC (1998) Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci U S A 95: 13812-13817.
17. Masopust D, Vezys V, Marzo AL, Lefrancois L (2001) Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
18. Keating R, Yue W, Rutigliano JA, So J, Olivas E, et al. (2007) Virus-specific CD8+ T cells in the liver: armed and ready to kill. J Immunol 178: 2737-2745.
19. Polakos NK, Klein I, Richter MV, Zaiss DM, Giannandrea M, et al. (2007) Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses. J Immunol 179: 201-210.
20. Ajuebor MN, Carey JA, Swain MG (2006) CCR5 in T cell-mediated liver diseases: what's going on? J Immunol 177: 2039-2045.
21. Peters MG (2002) Animal models of autoimmune liver disease. Immunol Cell Biol 80: 113-116.
22. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, et al. (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179: 1529-1537.
23. Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B (2001) Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 166: 5430-5438.
24. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, et al. (2004) The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114: 701-712.
25. Klein I, Crispe IN (2006) Complete differentiation of CD8+ T cells activated locally within the transplanted liver. J Exp Med 203: 437-447.
26. Wuensch SA, Pierce RH, Crispe IN (2006) Local intrahepatic CD8+ T cell activation by a non-self-antigen results in full functional differentiation. J Immunol 177: 1689-1697.
27. Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni S, et al. (2007) Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol 81: 4866-4871.
28. Shayakhmetov DM, Li ZY, Ni S, Lieber A (2004) Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J Virol 78: 5368-5381.
29. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79: 7478-7491.
30. Lukens JR, Cruise MW, Lassen MG, Hahn YS (2008) Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol 180: 4875-4884.
31. Krebs P, Scandella E, Odermatt B, Ludewig B (2005) Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J Immunol 174: 4559-4566.
32. Lawrence CW, Braciale TJ (2004) Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173: 1209-1218.
33. Holz LE, Benseler V, Bowen DG, Bouillet P, Strasser A, et al. (2008) Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 135: 989-997.
34. Radziewicz H, Ibegbu CC, Hon H, Osborn MK, Obideen K, et al. (2008) Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 82: 9808-9822.
35. Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, et al. (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81: 9249-9258.
36. Maier H, Isogawa M, Freeman GJ, Chisari FV (2007) PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 178: 2714-2720.
37. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8: 239-245.
38. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80: 11398-11403.
39. Gehring AJ, Sun D, Kennedy PT, Nolte-'t Hoen E, Lim SG, et al. (2007) The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol 81: 2940-2949.
40. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105: 5483-5488.
41. Willberg C, Barnes E, Klenerman P (2003) HCV immunology - death and the maiden T cell. Cell Death Differ 10 Suppl 1: S39-47.
42. Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, et al. (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828-837.
43. Isogawa M, Furuichi Y, Chisari FV (2005) Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 23: 53-63.
44. Ocana-Morgner C, Mota MM, Rodriguez A (2003) Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 197: 143-151.
45. Urban BC, Roberts DJ (2003) Inhibition of T cell function during malaria: implications for immunology and vaccinology. J Exp Med 197: 137-141.
46. Xiao Z, Mescher MF, Jameson SC (2007) Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J Exp Med 204: 2667-2677.
47. Cai Z, Kishimoto H, Brunmark A, Jackson MR, Peterson PA, et al. (1997) Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J Exp Med 185: 641-651.
48. Demotte N, Stroobant V, Courtoy PJ, Van Der Smissen P, Colau D, et al. (2008) Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes. Immunity 28: 414-424.
49. Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, et al. (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 5: e1000313.
50. Large MK, Kittlesen DJ, Hahn YS (1999) Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J Immunol 162: 931-938.
51. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS (2000) Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106: 1239-1249.